Literature DB >> 10871814

Prostate cancer: a comprehensive review.

S N Pentyala1, J Lee, K Hsieh, W C Waltzer, A Trocchia, L Musacchia, M J Rebecchi, S A Khan.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10871814     DOI： 10.1007/bf02796203

Source DB:  PubMed          Journal:  Med Oncol        ISSN： 1357-0560            Impact factor:   3.064


× No keyword cloud information.
  180 in total

1.  Down-regulation of protein and mRNA expression for transforming growth factor-beta (TGF-beta1) type I and type II receptors in human prostate cancer.

Authors:  Y Guo; S C Jacobs; N Kyprianou
Journal:  Int J Cancer       Date:  1997-05-16       Impact factor: 7.396

2.  The conversion of testosterone to 5-alpha-androstan-17-beta-ol-3-one by rat prostate in vivo and in vitro.

Authors:  N Bruchovsky; J D Wilson
Journal:  J Biol Chem       Date:  1968-04-25       Impact factor: 5.157

Review 3.  Hereditary prostate cancer: epidemiologic and clinical features.

Authors:  B S Carter; G S Bova; T H Beaty; G D Steinberg; B Childs; W B Isaacs; P C Walsh
Journal:  J Urol       Date:  1993-09       Impact factor: 7.450

4.  Three cases of hepatocellular carcinoma among cyproterone users. Ad hoc Committee on Androcur Users.

Authors:  S Watanabe; S Yamasaki; A Tanae; I Hibi; T Honna
Journal:  Lancet       Date:  1994-12-03       Impact factor: 79.321

5.  The results of prostate carcinoma screening in the U.S. as reflected in the surveillance, epidemiology, and end results program.

Authors:  C R Smart
Journal:  Cancer       Date:  1997-11-01       Impact factor: 6.860

6.  Differential nuclear matrix protein expression in prostate cancers: correlation with pathologic stage.

Authors:  Y Lakshmanan; E N Subong; A W Partin
Journal:  J Urol       Date:  1998-04       Impact factor: 7.450

7.  Correlation of prostate-specific antigen and prostate-specific antigen density with outcome of prostate biopsy.

Authors:  R Bare; L Hart; D L McCullough
Journal:  Urology       Date:  1994-02       Impact factor: 2.649

8.  Enhanced reverse transcriptase-polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage in patients with prostate cancer.

Authors:  A E Katz; G M de Vries; M D Begg; A J Raffo; C Cama; K O'Toole; R Buttyan; M C Benson; C A Olsson
Journal:  Cancer       Date:  1995-04-01       Impact factor: 6.860

9.  Rectal obstruction secondary to carcinoma of the prostate.

Authors:  D E Fry; M Amin; P J Harbrecht
Journal:  Ann Surg       Date:  1979-04       Impact factor: 12.969

10.  The significance of isoechoic prostatic carcinoma.

Authors:  W J Ellis; M K Brawer
Journal:  J Urol       Date:  1994-12       Impact factor: 7.450
View more
  11 in total

1.  Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer.

Authors:  Annika Rökman; Tarja Ikonen; Eija H Seppälä; Nina Nupponen; Ville Autio; Nina Mononen; Joan Bailey-Wilson; Jeffrey Trent; John Carpten; Mika P Matikainen; Pasi A Koivisto; Teuvo L J Tammela; Olli-P Kallioniemi; Johanna Schleutker
Journal:  Am J Hum Genet       Date:  2002-04-08       Impact factor: 11.025

2.  Moderate physical activity and prostate cancer risk: a case-control study in China.

Authors:  Le Jian; Zhou Jun Shen; Andy H Lee; Colin W Binns
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

3.  A snapshot of waiting times for cancer surgery provided by surgeons affiliated with regional cancer centres in Ontario.

Authors:  M Simunovic; A Gagliardi; D McCready; A Coates; M Levine; D DePetrillo
Journal:  CMAJ       Date:  2001-08-21       Impact factor: 8.262

4.  Ductal variant of prostate adenocarcinoma harbor Xenotropic murine leukemia virus related virus (XMRV) infection: a novel finding in subtype of prostate cancer.

Authors:  Faraz Ahmed Baig; Talat Mirza; Amna Hamid; Serajuddaula Syed; Qamar Jamal
Journal:  Turk J Urol       Date:  2017-07-31

5.  Metabolic syndrome in sub-Saharan Africa: "smaller twin" of a region's prostatic diseases?

Authors:  Chukwunonso E C C Ejike; Lawrence U S Ezeanyika
Journal:  Int Urol Nephrol       Date:  2008-02-21       Impact factor: 2.370

6.  The use of zoledronic acid in Japanese men with stage D2 prostate cancer.

Authors:  Kogenta Nakamura; Yoshiaki Yamada; Charles J Rosser; Maki Arakawa; Kenji Zennmai; Yoshiharu Kato; Masahito Watanabe; Remi Katsuda; Motoi Tobiume; Katsuya Naruse; Shigeyuki Aoki; Tomohiro Taki; Hiroko Saito; Takaaki Hasegawa; Nobuaki Honda
Journal:  Oncol Lett       Date:  2010-01-01       Impact factor: 2.967

7.  Risk of osteonecrosis of the jaw in cancer patients receiving denosumab: a meta-analysis of seven randomized controlled trials.

Authors:  Wei-Xiang Qi; Li-Na Tang; Ai-Na He; Yang Yao; Zan Shen
Journal:  Int J Clin Oncol       Date:  2013-04-20       Impact factor: 3.402

8.  Establishment and validation of an in vitro co-culture model to study the interactions between bone and prostate cancer cells.

Authors:  Annika Nordstrand; Jonas Nilsson; Ase Tieva; Pernilla Wikström; Ulf H Lerner; Anders Widmark
Journal:  Clin Exp Metastasis       Date:  2009-09-01       Impact factor: 5.150

9.  The targeted inhibition of prostate cancer by iron-based nanoparticles based on bioinformatics.

Authors:  Feng Xiao; Jiayu Liu; Yongbo Zheng; Zhen Quan; Wei Sun; Yao Fan; Chunli Luo; Hailiang Li; Xiaohou Wu
Journal:  J Biomater Appl       Date:  2020-12-06       Impact factor: 2.646

10.  Functional and Structural Consequences of Damaging Single Nucleotide Polymorphisms in Human Prostate Cancer Predisposition Gene RNASEL.

Authors:  Amit Datta; Md Habibul Hasan Mazumder; Afrin Sultana Chowdhury; Md Anayet Hasan
Journal:  Biomed Res Int       Date:  2015-07-08       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.